Introduction As the Medicare Advantage (MA) program continues to evolve, so does the robust competition among health plans to attract new members. Enrollment in MA has surged past 30 million (more than half of all...more
Medicare Advantage (MA) is the private plan option in the Medicare program. Enrollment in the program has surged in the past decade and now tops 30 million — nearly half of all Medicare enrollees. Notably, MA is the preferred...more
Each year, the health plans that participate in the Medicare Advantage (MA) program compete vigorously for new members. Enrollment in the program has grown to over 28 million Americans, making 2023 a more competitive year...more
Each year, the health plans that participate in Medicare Advantage (MA) program compete vigorously for new members. This vigorous competition has fueled the program’s 10% annual growth rate in recent years. MA plans can...more
It was a week of welcome news and encouraging milestones in the COVID-19 response, especially in the U.S., where the federal government passed a $1.9 trillion COVID-19 relief package and President Biden announced a goal to...more
Medicare Advantage (MA) is the private plan option in the Medicare program. Enrollment in the program has grown nearly 10% a year in recent years and now tops 25 million. More than one-third of Medicare beneficiaries (people...more
With Democrats having slight majorities in the House and Senate and Joe Biden in the White House, the Congressional Review Act (CRA) becomes an available tool to potentially vacate certain regulations that the outgoing Trump...more
Medicare Advantage (MA) is the rapidly growing private plan option in the Medicare program. More than one-third of all Medicare beneficiaries choose MA — more than 24 million people. The program has grown nearly 10% year over...more
AstraZeneca’s Phase 3 vaccine clinical trials came to a halt this week as the pharmaceutical company works to identify the underlying cause of a case of transverse myelitis emerging in a volunteer. The pause coincided with...more
Background -
Amid the stalemate surrounding a new COVID-19 response bill, Senate Republicans are circulating a new COVID-19 stimulus package that they intend to serve as their response to the House Democrats’ $25 billion...more
Through a series of recent hearings, the United States Congress delved into the federal government’s response to the COVID-19 pandemic. This series of congressional hearings examined the current outbreak across several...more
Medicare Advantage (MA) is the private plan option in the Medicare program. Over the last few years, the program has grown rapidly, nearly 10% a year. More than one-third of Medicare beneficiaries (people with Medicare) have...more
Following days of protracted negotiations, Congress is heading toward enacting a $2 trillion measure to respond to the coronavirus pandemic. Anticipated to clear the House of Representatives on Friday and be promptly signed...more
One day after H.R. 6201, the Families First Coronavirus Response Act, a relief package, was signed into law, Senate Republicans threw down their marker for an even more significant phase three relief package that includes...more
The Trump administration and state government agencies have been responding to the escalating coronavirus (COVID-19) public emergency by prioritizing funding opportunities and strategizing ways to increase access to care and...more